Loading insider details...
Beta
Latest Form 4 (Aug 26, 2026): Grant/Award of 2,900,026 GOSS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 26, 2026 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 2,900,026 | n/a |
| Mar 20, 2026 | Gossamer Bio, Inc. (GOSS) | Disposition to Issuer | 506,250 | n/a |
| Feb 3, 2026 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/Award | 53,960 | n/a |
| Jan 5, 2026 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 84,500 | n/a |
| Oct 2, 2025 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 125,000 | n/a |
| Mar 6, 2025 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 440,000 | n/a |
| Feb 3, 2025 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/Award | 17,950 | n/a |
| Mar 28, 2024 | Gossamer Bio, Inc. (GOSS) | Sale | 6,430 | $7.4K |
| Jan 19, 2024 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/Award | 13,948 | n/a |
| Jan 4, 2024 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 375,000 | n/a |